Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $37.3 million.

  • Sotera Health's Receivables - Other rose 2254.66% to $37.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.3 million, marking a year-over-year increase of 2254.66%. This contributed to the annual value of $15.2 million for FY2024, which is 1446.16% down from last year.
  • Per Sotera Health's latest filing, its Receivables - Other stood at $37.3 million for Q3 2025, which was up 2254.66% from $28.6 million recorded in Q2 2025.
  • Sotera Health's 5-year Receivables - Other high stood at $37.3 million for Q3 2025, and its period low was $14.0 million during Q2 2021.
  • Its 5-year average for Receivables - Other is $20.6 million, with a median of $18.7 million in 2023.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 5530.64% in 2022, then plummeted by 1446.16% in 2024.
  • Sotera Health's Receivables - Other (Quarter) stood at $15.6 million in 2021, then grew by 26.78% to $19.8 million in 2022, then decreased by 10.07% to $17.8 million in 2023, then decreased by 14.46% to $15.2 million in 2024, then surged by 145.02% to $37.3 million in 2025.
  • Its last three reported values are $37.3 million in Q3 2025, $28.6 million for Q2 2025, and $17.6 million during Q1 2025.